Outbreaks of filovirus hemorrhagic fever: Time to refocus on the patient

Journal of Infectious Diseases

Volumn 196, Issue SUPPL. 2, 2007, Pages

  Bausch, Daniel G ^a   Feldmann, Heinz ^e   Geisbert, Thomas W ^b   Bray, Mike ^c   Sprecher, A G ^f   Boumandouki, Paul ^g   Rollin, Pierre E ^d   Roth, Cathy ^h  

^a TULANE UNIVERSITY   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

^f MÉDECINS SANS FRONTIÈRES   (Belgium)

^g Ministry of Health and Population   (Congo)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

CLINICAL RESEARCH; CONFERENCE PAPER; EBOLA VIRUS; EPIDEMIC; FILOVIRUS; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; LABORATORY TEST; MARBURG VIRUS; PRIORITY JOURNAL; VIRUS HEMORRHAGIC FEVER; VIRUS ISOLATION; VIRUS TRANSMISSION; ARTICLE; DISEASE TRANSMISSION; FILOVIRIDAE; ISOLATION AND PURIFICATION; PATHOGENICITY; PROTECTIVE CLOTHING; RESEARCH; VIRUS INFECTION;

DISEASE OUTBREAKS; FILOVIRIDAE; FILOVIRIDAE INFECTIONS; HEMORRHAGIC FEVERS, VIRAL; HUMANS; PROTECTIVE CLOTHING; RESEARCH; VIRAL VACCINES;

EID: 38449108229     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520542     Document Type: Conference Paper

References (27)

1. Peters CJ, Zaki SR. Overview of viral hemorrhagic fevers. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens, and practice. Vol 1. Philadelphia, PA: Churchill Livingstone, 2006:726-33.
2. Larkin M. Ebola outbreak in the news. Lancet Infect Dis 2003; 3:255.
3. Bausch D. Of sickness unknown: death, and health, in Africa. United Nations Chronicle 2001; 38:5-13.
4. Boumandouki P, Formenty P, Epelboin A, et al. Clinical management of patients and deceased during the Ebola outbreak from October to December 2003 in Republic of Congo [in French]. Bull Soc Pathol Exot 2005; 98:218-23.
5. Schuler A. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006. Biosecur Bioterror 2005; 3:94-101.
6. Jones SM, Feldmann H, Stroher U, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 2005; 11:786-90.
7. Daddario-Dicaprio KM, Geisbert TW, Geisbert JB, et al. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol 2006; 80:9659-66.
8. Sullivan NJ, Geisbert TW, Geisbert JB, et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 2003; 424:681-4.
9. Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature 2000; 408:605-9.
10. Martin JE, Sullivan NJ, Enama ME, et al. A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clin Vaccine Immunol 2006; 13:1267-77.
11. Geisbert TW, Hensley LE, Jahrling PB, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 2003; 362:1953-8.
12. Parren PW, Geisbert TW, Maruyama T, Jahrling PB, Burton DR. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Virol 2002; 76:6408-12.
13. Geisbert TW, Hensley LE, Kagan E, et al. Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J Infect Dis 2006; 193:1650-7.
14. Enterlein S, Warfield KL, Swenson DL, et al. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother 2006; 50:984-93.
15. Daddario-Dicaprio KM, Geisbert TW, Stroher U, et al. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet 2006; 367:1399-404.
16. Hewlett BS, Epelboin A, Hewlett BL, Formenty P. Medical anthropology and Ebola in Congo: cultural models and humanistic care. Bull Soc Pathol Exot 2005; 98:230-6.
17. Centers for Disease Control and Prevention (CDC), World Health Organization. Infection control for viral haemorrhagic fevers in the African health care setting. Atlanta: CDC, 1998.
18. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999; 179(Suppl 1):S76-86.
19. Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis 1999; 179(Suppl 1):S259-62.
20. Bausch DG. Ebola and Marburg viruses. In: Goldmann DR, ed. Physicians' information and education resource. Philadelphia, PA: American College of Physicians, 2007.
21. Jeffs B. A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa. Trop Doct 2006; 36:1-4.
22. Nkoghe D, Formenty P, Nnegue S, et al. Practical guidelines for the management of Ebola infected patients in the field [in French]. Med Trop (Mars) 2004; 64:199-204.
23. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41.
24. Weidmann M, Muhlberger E, Hufert FT. Rapid detection protocol for filoviruses. J Clin Virol 2004; 30:94-9.
25. Grolla A, Lucht A, Dick D, Strong JE, Feldmann H. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot 2005; 98:205-9.
26. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709.
27. Lamunu M, Lutwama JJ, Kamugisha J, et al. Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001). Int J Infect Dis 2004; 8:27-37.